EUVIMEDOpdag EUVIMED
Crossref

Role of aptamer technology in extracellular vesicle biology and therapeutic application

Rocky Chowdhury, Seyed Sadegh Eslami, Cuong Pham, Alin Rai, Jia Lin, Yingchun Hou, David W. Greening, Wei Duan

La Trobe University · 2024-06-28

DOI: 10.26181/32142175 ↗

At a glance

Journal article in La Trobe University, published on 2024-06-28. Written by Rocky Chowdhury and 7 co-authors.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Extracellular vesicles (EVs) are cell-derived nanosized membrane-bound vesicles that are important intercellular signalling regulators in local cell-to-cell and distant cell-to-tissue communication. Their inherent capacity to transverse cell membranes and transfer complex bioactive cargo reflective of their cell source, as well as their ability to be modified through various engineering and modification strategies, have attracted significant therapeutic interest. Molecular bioengineering strategies are providing a new frontier for EV-based therapy, including novel mRNA vaccines, antigen cross-presentation and immunotherapy, organ delivery and repair, and cancer immune surveillance and targeted therapeutics. The revolution of EVs, their diversity as biocarriers and their potential to contribute to intercellular communication, is well understood and appreciated but is ultimately dependent on the development of methods and techniques for their isolation, characterization and enhanced targeting. As single-stranded oligonucleotides, aptamers, also known as chemical antibodies, offer significant biological, chemical, economic, and therapeutic advantages in terms of their size, selectivity, versatility, and multifunctional programming. Their integration into the field of EVs has been contributing to the development of isolation, detection, and analysis pipelines associated with bioengineering strategies for nano-meets-molecular biology, thus translating their use for therapeutic and diagnostic utility.

Subjects

extracellular vesiclesaptamersEV-based therapeuticsEV isolationEV characterizationintercellular communicationmRNA vaccinescross-presentationimmunotherapyorgan restoration

Cite

APA

Chowdhury, R., Eslami, S. S., Pham, C., Rai, A., Lin, J., Hou, Y., Greening, D. W., & Duan, W. (2024). Role of aptamer technology in extracellular vesicle biology and therapeutic application. La Trobe University. https://doi.org/10.26181/32142175

Vancouver

Chowdhury R, Eslami SS, Pham C, Rai A, Lin J, Hou Y, et al. Role of aptamer technology in extracellular vesicle biology and therapeutic application. La Trobe University. 2024. doi:10.26181/32142175

BibTeX
@article{Chowdhury2024,
  author = {Chowdhury, Rocky and Eslami, Seyed Sadegh and Pham, Cuong and Rai, Alin and Lin, Jia and Hou, Yingchun and Greening, David W. and Duan, Wei},
  title = {Role of aptamer technology in extracellular vesicle biology and therapeutic application},
  journal = {La Trobe University},
  year = {2024},
  doi = {10.26181/32142175}
}
Start for free →